PortfoliosLab logoPortfoliosLab logo
ULBI vs. LII
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ULBI vs. LII - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ultralife Corporation (ULBI) and Lennox International Inc. (LII). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ULBI achieves a 20.72% return, which is significantly higher than LII's 6.43% return. Over the past 10 years, ULBI has underperformed LII with an annualized return of 4.85%, while LII has yielded a comparatively higher 15.46% annualized return.


ULBI

1D
-2.88%
1M
4.31%
YTD
20.72%
6M
22.21%
1Y
-4.76%
3Y*
14.67%
5Y*
-5.76%
10Y*
4.85%

LII

1D
-0.21%
1M
0.09%
YTD
6.43%
6M
3.63%
1Y
-7.15%
3Y*
21.18%
5Y*
9.89%
10Y*
15.46%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ULBI vs. LII - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ULBI
Ultralife Corporation
20.72%-23.22%9.24%76.68%-36.09%-6.65%-12.45%9.48%3.05%32.32%
LII
Lennox International Inc.
6.43%-19.54%37.27%89.55%-24.94%19.71%13.79%12.78%6.33%37.43%

Correlation

The correlation between ULBI and LII is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.24

Correlation (3Y)
Calculated over the trailing 3-year period

0.29

Correlation (5Y)
Calculated over the trailing 5-year period

0.26

Correlation (10Y)
Calculated over the trailing 10-year period

0.21

Correlation (All Time)
Calculated using the full available price history since Jul 30, 1999

0.18

The correlation between ULBI and LII shifts across timeframes, from 0.18 (all time) to 0.29 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ULBI:

$115.02M

LII:

$18.04B

EPS

ULBI:

-$0.49

LII:

$22.20

PS Ratio

ULBI:

0.61

LII:

3.46

PB Ratio

ULBI:

0.89

LII:

14.86

Total Revenue (TTM)

ULBI:

$187.86M

LII:

$5.26B

Gross Profit (TTM)

ULBI:

$43.39M

LII:

$1.74B

EBITDA (TTM)

ULBI:

$6.73M

LII:

$1.10B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ULBI vs. LII — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ULBI
ULBI Risk / Return Rank: 3737
Overall Rank
ULBI Sharpe Ratio Rank: 3737
Sharpe Ratio Rank
ULBI Sortino Ratio Rank: 3737
Sortino Ratio Rank
ULBI Omega Ratio Rank: 3737
Omega Ratio Rank
ULBI Calmar Ratio Rank: 3737
Calmar Ratio Rank
ULBI Martin Ratio Rank: 3737
Martin Ratio Rank

LII
LII Risk / Return Rank: 3131
Overall Rank
LII Sharpe Ratio Rank: 3232
Sharpe Ratio Rank
LII Sortino Ratio Rank: 2828
Sortino Ratio Rank
LII Omega Ratio Rank: 2929
Omega Ratio Rank
LII Calmar Ratio Rank: 3333
Calmar Ratio Rank
LII Martin Ratio Rank: 3434
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ULBI vs. LII - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ultralife Corporation (ULBI) and Lennox International Inc. (LII). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ULBILIIDifference

Sharpe ratio

Return per unit of total volatility

-0.08

-0.21

+0.12

Sortino ratio

Return per unit of downside risk

0.30

-0.05

+0.35

Omega ratio

Gain probability vs. loss probability

1.04

0.99

+0.04

Calmar ratio

Return relative to maximum drawdown

-0.11

-0.21

+0.11

Martin ratio

Return relative to average drawdown

-0.17

-0.35

+0.17

ULBI vs. LII - Sharpe Ratio Comparison

The current ULBI Sharpe Ratio is -0.08, which is higher than the LII Sharpe Ratio of -0.21. The chart below compares the historical Sharpe Ratios of ULBI and LII, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ULBILIIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.08

-0.21

+0.12

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.10

0.31

-0.41

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.09

0.53

-0.44

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.03

0.43

-0.46

Drawdowns

ULBI vs. LII - Drawdown Comparison

The maximum ULBI drawdown since its inception was -92.90%, which is greater than LII's maximum drawdown of -62.76%. Use the drawdown chart below to compare losses from any high point for ULBI and LII.


Loading charts...

Drawdown Indicators


ULBILIIDifference

Max Drawdown

Largest peak-to-trough decline

-92.90%

-62.76%

-30.14%

Max Drawdown (1Y)

Largest decline over 1 year

-44.69%

-33.77%

-10.92%

Max Drawdown (3Y)

Largest decline over 3 years

-68.83%

-34.71%

-34.12%

Max Drawdown (5Y)

Largest decline over 5 years

-68.83%

-46.88%

-21.95%

Max Drawdown (10Y)

Largest decline over 10 years

-68.83%

-46.88%

-21.95%

Current Drawdown

Current decline from peak

-71.82%

-22.94%

-48.88%

Average Drawdown

Average peak-to-trough decline

-63.48%

-14.50%

-48.98%

Ulcer Index

Depth and duration of drawdowns from previous peaks

27.26%

20.59%

+6.67%

Volatility

ULBI vs. LII - Volatility Comparison

Ultralife Corporation (ULBI) has a higher volatility of 25.54% compared to Lennox International Inc. (LII) at 10.19%. This indicates that ULBI's price experiences larger fluctuations and is considered to be riskier than LII based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ULBILIIDifference

Volatility (1M)

Calculated over the trailing 1-month period

25.54%

10.19%

+15.35%

Volatility (6M)

Calculated over the trailing 6-month period

41.68%

25.93%

+15.75%

Volatility (1Y)

Calculated over the trailing 1-year period

58.55%

34.81%

+23.74%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

59.02%

32.04%

+26.98%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

55.19%

29.26%

+25.93%

Dividends

ULBI vs. LII - Dividend Comparison

ULBI has not paid dividends to shareholders, while LII's dividend yield for the trailing twelve months is around 1.01%.


PositionTTM20252024202320222021202020192018201720162015
LII
Lennox International Inc.
1.01%1.04%0.75%0.97%1.71%1.09%1.12%1.21%1.11%0.94%1.08%1.10%
ULBI
Ultralife Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

ULBI vs. LII - Financials Comparison

This section allows you to compare key financial metrics between Ultralife Corporation and Lennox International Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B20222023202420252026
47.45M
1.14B
(ULBI) Total Revenue
(LII) Total Revenue
Values in USD except per share items

ULBI vs. LII - Profitability Comparison

The chart below illustrates the profitability comparison between Ultralife Corporation and Lennox International Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%25.0%30.0%35.0%20222023202420252026
21.3%
31.0%
Portfolio components
ULBI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Ultralife Corporation reported a gross profit of 10.11M and revenue of 47.45M. Therefore, the gross margin over that period was 21.3%.

LII - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Lennox International Inc. reported a gross profit of 351.30M and revenue of 1.14B. Therefore, the gross margin over that period was 31.0%.

ULBI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Ultralife Corporation reported an operating income of -215.00K and revenue of 47.45M, resulting in an operating margin of -0.5%.

LII - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Lennox International Inc. reported an operating income of 163.50M and revenue of 1.14B, resulting in an operating margin of 14.4%.

ULBI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Ultralife Corporation reported a net income of -451.00K and revenue of 47.45M, resulting in a net margin of -1.0%.

LII - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Lennox International Inc. reported a net income of 117.20M and revenue of 1.14B, resulting in a net margin of 10.3%.


Frequently Asked Questions


ULBI and LII have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ULBI has higher volatility (25.54%) compared to LII (10.19%). In terms of maximum drawdown, ULBI dropped -92.90% vs LII's -62.76%.

ULBI currently has the higher Sharpe Ratio (-0.08 vs -0.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ULBI and LII

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer